May 18, 2026 04:46PM
Apr 30, 2026 06:22AM
Apr 30, 2026 06:00AM
Feb 5, 2026 07:24AM
Nov 20, 2025 07:45AM
Nov 17, 2025 06:26AM
Aug 4, 2025 04:33PM OS Therapies (OSTX) Files for 3.76M Share Offering by Selling Stockholders
Jul 3, 2025 07:41AM
Jun 30, 2025 06:02AM
Jun 24, 2025 07:41AM
Jun 10, 2025 07:40AM
Jun 6, 2025 07:31AM
May 16, 2025 04:34PM
May 7, 2025 08:45AM OS Therapies (OSTX) Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Imm
Apr 22, 2025 07:41AM
Apr 22, 2025 07:34AM
Apr 9, 2025 07:40AM
Mar 31, 2025 07:40AM
Feb 24, 2025 07:25AM
Feb 20, 2025 05:54AM
Feb 14, 2025 07:36AM OS Therapies (OSTX) Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing
Feb 4, 2025 07:33AM
Jan 15, 2025 07:45AM
Dec 31, 2024 03:38PM
Dec 26, 2024 10:03AM
Dec 24, 2024 09:32AM
Oct 28, 2024 04:44PM
Sep 13, 2024 08:09AM OS Therapies (OSTX) Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
Sep 3, 2024 07:17AM
Aug 29, 2024 07:53AM
Aug 22, 2024 01:01PM
Aug 2, 2024 08:56AM
Jul 24, 2024 10:50AM

405,014 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All